160 results
Page 4 of 8
8-K
EX-99.3
zsrwxo
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
EX-99.2
wkqhq
21 Apr 21
Regulation FD Disclosure
7:05am
8-K
EX-99.1
y6sr49a7
18 Mar 21
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
7:01am
8-K
EX-99.2
a9ugi5c2964p6z
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
8-K
EX-99.1
glbxtp01
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
424B5
39ui1ddpv8 rblt1ldfb
31 Dec 20
Prospectus supplement for primary offering
4:57pm
8-K
EX-99.1
p97xgqv zfyxfw20fs5f
2 Nov 20
Regulation FD Disclosure
9:22am
8-K
EX-99.1
4g549 j2k
30 Oct 20
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
8:00am
424B5
ic35tfd zpqjmfs
13 Aug 20
Prospectus supplement for primary offering
12:00am
424B5
hrr3ko8k
11 Aug 20
Prospectus supplement for primary offering
4:23pm
8-K
EX-99.2
xh7cc5
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
EX-99.1
s6h7sx3
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
EX-99.1
5t1gcjxcu5o14v guoy
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
1ptru og4x0
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
EX-99.2
3ml05
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
EX-99.1
5zrs611 tqj
18 May 20
Regulation FD Disclosure
5:21pm
8-K
ju3k29i
18 May 20
Regulation FD Disclosure
7:00am